Cargando…
Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
There is currently an unmet need for effective treatment of chronic kidney disease (CKD) that slows disease progression, prevents development of end-stage kidney disease and cardiovascular disease, and prolongs survival of patients with CKD. In the last 20 years, the only agents to show a reduction...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799531/ https://www.ncbi.nlm.nih.gov/pubmed/34846711 http://dx.doi.org/10.1007/s12325-021-01994-2 |